1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Tengfu Medical

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2020

Location

Shenzhen guangdong China

Primary Industry

Medical Devices & Equipment

About

Established in 2020, Tengfu Medical is a Medical device developer that provides R&D, production and sales of pulmonary embolism intervention medical devices. The company is mainly involved in the field of two main disease areas include pulmonary embolism and deep vein thrombosis. The company has completed 4 rounds of funding as of 2022. The company specializes in the development of pulmonary artery thrombosis systems. The company self-developed pulmonary artery thrombosis systems has the function of remove bleeding clots, restore blood flow to the pulmonary vessels and save lives. The company plans to use the series A+ funding for the clinical registration and marketing of interventional devices for acute pulmonary embolism, as well as promoting the development and clinical research of other products for venous thromboembolism treatment.
Current Investors
Vinno Capital, Cowin Capital, K2VC

Request a demo to show more

Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Equipment Distributors, Surgical Devices
Verticals
HealthTech
Company Stage
Series A
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.